• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by AdvanSix Inc.

    7/2/25 4:49:08 PM ET
    $ASIX
    Major Chemicals
    Industrials
    Get the next $ASIX alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001806189
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    AdvanSix Inc.
    SEC File Number
    001-37774
    Address of Issuer
    300 KIMBALL DRIVE
    SUITE 101
    PARSIPPANY
    NEW JERSEY
    07054
    Phone
    (973) 526-1800
    Name of Person for Whose Account the Securities are To Be Sold
    Kintiroglou Achilles B.
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock
    Merrill Lynch
    225 Liberty St
    Floor 37
    New York � NY � 10281
    57114189.352681268707/02/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Stock02/28/2024Vesting of restricted stock unit awardAdvanSix Inc.Checkbox not checked57102/28/2024Granted as part of issuer equity compensation plan

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Achilleus Kintiroglou
    300 KIMBALL DRIVE
    PARSIPPANY � NJ � 07054
    Common Stock05/01/2025323769077.58
    Achilleus Kintiroglou
    300 KIMBALL DRIVE
    PARSIPPANY � NJ � 07054
    Common Stock06/02/202557113504.15

    144: Remarks and Signature

    Remarks
    Date of Notice
    07/02/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    11/12/2024

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    Achilleus Kintiroglou

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $ASIX alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $ASIX

    DatePrice TargetRatingAnalyst
    5/19/2025$32.00Neutral → Overweight
    Piper Sandler
    4/7/2025$26.00Overweight → Neutral
    Piper Sandler
    11/12/2021$58.00Overweight
    Piper Sandler
    More analyst ratings

    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, General Counsel Kintiroglou Achilles B. sold $14,189 worth of shares (571 units at $24.85), decreasing direct ownership by 2% to 31,984 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/2/25 4:30:47 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • Director Williams Patrick was granted 552 shares, increasing direct ownership by 2% to 34,193 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/1/25 4:42:44 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • Director Newman Donald P was granted 977 shares, increasing direct ownership by 9% to 12,026 units (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      7/1/25 4:38:50 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Newman Donald P bought $149,089 worth of shares (5,030 units at $29.64) (SEC Form 4)

      4 - AdvanSix Inc. (0001673985) (Issuer)

      11/19/24 4:20:20 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    SEC Filings

    See more
    • SEC Form 144 filed by AdvanSix Inc.

      144 - AdvanSix Inc. (0001673985) (Subject)

      7/2/25 4:49:08 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form S-8 filed by AdvanSix Inc.

      S-8 - AdvanSix Inc. (0001673985) (Filer)

      6/20/25 4:20:25 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - AdvanSix Inc. (0001673985) (Filer)

      6/20/25 4:07:25 PM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AdvanSix upgraded by Piper Sandler with a new price target

      Piper Sandler upgraded AdvanSix from Neutral to Overweight and set a new price target of $32.00

      5/19/25 8:45:52 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix downgraded by Piper Sandler with a new price target

      Piper Sandler downgraded AdvanSix from Overweight to Neutral and set a new price target of $26.00

      4/7/25 8:48:39 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • Piper Sandler initiated coverage on AdvanSix with a new price target

      Piper Sandler initiated coverage of AdvanSix with a rating of Overweight and set a new price target of $58.00

      11/12/21 4:57:29 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Leadership Updates

    Live Leadership Updates

    See more
    • AdvanSix Appoints Sidd Manjeshwar as Senior Vice President and Chief Financial Officer

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Sidd Manjeshwar as Senior Vice President and Chief Financial Officer, effective October 1st. In this role, Mr. Manjeshwar will have global responsibility for controllership, treasury, investor relations, procurement, internal audit, commercial finance, tax and financial planning and analysis for the enterprise. Mr. Manjeshwar will report directly to Erin Kane, President and CEO of AdvanSix, and be a member of the Company's executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240911629335/en/Sidd Manjeshwar, incoming SVP

      9/12/24 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Donald P. Newman to Board of Directors

      AdvanSix (NYSE:ASIX), a diversified chemistry company, announced today the appointment of Donald P. Newman as a new independent member of its Board of Directors. Mr. Newman is currently Executive Vice President, Finance and Chief Financial Officer of ATI Inc., a global producer of high-performance materials and solutions for the global aerospace and defense markets and critical applications in electronics, medical and specialty energy. Mr. Newman will serve on the Audit Committee and the Health, Safety and Environmental Committee of the Board of Directors. AdvanSix's Board now consists of nine members, including eight independent directors. "Don is well recognized for his financial expert

      8/19/24 4:30:00 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Appoints Farha Aslam to Board of Directors

      AdvanSix (NYSE:ASIX) announced today the appointment of Farha Aslam as a new independent member of its Board of Directors. Ms. Aslam is currently Managing Partner of Crescent House Capital, an investment and strategic advisory firm she founded that focuses on the agriculture, energy and food processing industries. Ms. Aslam will serve on the Audit Committee and the Compensation and Leadership Development Committee of the Board of Directors. AdvanSix's Board now consists of 10 members, including nine independent directors. "We are very excited to welcome Farha to the AdvanSix Board and leverage her agribusiness experience and financial expertise to progress our corporate strategic prioritie

      12/14/21 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/13/24 4:55:58 PM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G/A filed by AdvanSix Inc. (Amendment)

      SC 13G/A - AdvanSix Inc. (0001673985) (Subject)

      2/9/24 9:58:57 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • SEC Form SC 13G filed by AdvanSix Inc.

      SC 13G - AdvanSix Inc. (0001673985) (Subject)

      2/7/24 8:39:58 AM ET
      $ASIX
      Major Chemicals
      Industrials

    $ASIX
    Financials

    Live finance-specific insights

    See more
    • AdvanSix Announces First Quarter 2025 Financial Results

      1Q25 Sales of $378 million, up 12% versus prior year 1Q25 Earnings Per Share of $0.86; Adjusted Earnings Per Share of $0.93 1Q25 Cash Flow from Operations of $11 million, up $48 million versus prior year 1Q25 results include previously announced $26 million final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the first quarter ending March 31, 2025. Overall, year-over-year results reflect improved operational performance, continued strength in Plant Nutrients, and the previously announced insurance settlement proceeds. First Quarter 2025 Summary Sales up approximately

      5/2/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix to Release First Quarter Financial Results and Hold Investor Conference Call on May 2

      AdvanSix (NYSE:ASIX), a diversified chemistry company, will issue its first quarter 2025 financial results before the opening of the New York Stock Exchange on Friday, May 2. The company will also hold a conference call with investors at 9:30 a.m. ET that day. Conference Call Details To participate on the conference call, dial (844) 855-9494 (domestic) or (412) 858-4602 (international) approximately 10 minutes before the 9:30 a.m. ET start and tell the operator that you are dialing in for AdvanSix's first quarter 2025 earnings call. A replay of the conference call will be available from 12 noon ET on May 2 until 12 noon ET on May 9. You can listen to the replay by dialing (877) 344-7529 (

      4/8/25 6:45:00 AM ET
      $ASIX
      Major Chemicals
      Industrials
    • AdvanSix Announces Fourth Quarter and Full Year 2024 Financial Results

      4Q24 Sales of $329 million, down 14% versus prior year 4Q24 Earnings Per Share of $0.01; Adjusted Earnings Per Share of $0.09 4Q24 Cash Flow from Operations of $64 million, up $4 million versus prior year Progressing 45Q carbon capture tax credits with initial $9.7 million claimed in 4Q24 Final insurance settlement proceeds related to 2019 PES supplier shutdown AdvanSix (NYSE:ASIX), a diversified chemistry company, today announced its financial results for the fourth quarter and full year ending December 31, 2024. Overall, in 2024, the Company achieved commercial success and advanced targeted growth initiatives, while navigating operational challenges in the year. Full Year 2024 Summa

      2/21/25 6:30:00 AM ET
      $ASIX
      Major Chemicals
      Industrials